Dr. Grossman’s Blog

Antioxidant and omega-3 supplements continue to be a simple, low-cost, effective therapy for AMD

A study designed to measure changes in visual function in subjects with atrophic (dry) age-related macular degeneration (AMD) found that three-quarters of the subjects receiving a nutritional supplement demonstrated stabilization or improvement of visual acuity at 6 months.

Dry, atrophic, or non-exudative, AMD is the most common form of macular degeneration.  Risk factors for dry AMD include:

• age greater than 50
• Caucasian race
• poor nutrition
• smoking
• atherosclerotic vascular disease
• genetics 
• sunlight exposure.

Multiple studies have suggested that nutritional factors can play a significant role in slowing the onset or limiting the effects of AMD.  The Taurine, Omega-3 Fatty Acids, Zinc, Antioxidant, Lutein (TOZAL) study tried to identify the potential benefits of a new supplement designed to limit the risk of AMD and progressive vision loss.

In this study, published in BMC Ophthalmology, 37 mixed gender patients (average age 76 years) at 5 independent study sites received a nutritional supplement specifically formulated to combat AMD.   This supplement included natural beta-carotene, vitamins A and E, zinc, and copper.   Results were compared to subjects in other tests who had been given placebos.

76.7% of subjects receiving the nutritional supplement demonstrated stabilization or improvement of visual acuity at 6 months.

Read other studies about AMD

Learn more about antioxidants and food sources for nutrients important for good eye health

SOURCE:  TOZAL Study: An open case control study of an oral antioxidant and omega-3 supplement for dry AMD, Cangemi, BMC Ophthalmology 2007, 7:3doi:10.1186/1471-2415-7-3.